Trials / Completed
CompletedNCT01029678
Concomitant Radio-chemotherapy in the Elderly
Phase II Study Evaluating Treatment With Oral Navelbine and Cisplatin Administered Weekly and Concomitant Radiotherapy in Elderly Patients With no Operable NSCLC
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 48 (actual)
- Sponsor
- University Hospital, Limoges · Academic / Other
- Sex
- All
- Age
- 70 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the safety of non small cell lung cancer (NSCLC) treatment with cisplatin and oral vinorelbine administered weekly associated with concomitant radiotherapy in elderly patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Cisplatin IV | Cisplatin IV 30 mg/m2/ (Day 1, Day 8, Day 15, Day 22, Day 29, Day 36) |
| DRUG | Vinorelbine | Vinorelbine per os 30 mg/m2/(day1, day8, day15, day22, day29, day36 |
| RADIATION | Radiotherapy | 66Gy, 33 fractions, 6 week |
Timeline
- Start date
- 2010-01-01
- Primary completion
- 2015-01-01
- Completion
- 2016-06-01
- First posted
- 2009-12-10
- Last updated
- 2018-05-03
Locations
5 sites across 1 country: France
Source: ClinicalTrials.gov record NCT01029678. Inclusion in this directory is not an endorsement.